Lisdexamfetamine Dimesylate recalls
Lisdexamfetamine Dimesylate products have been recalled 8 times, most recently on 5 Nov 2025. The recalling company is usually SUN Pharmaceutical Industries. The most common reason is potency & assay.
Total recalls8since 2025
Last 12 months7reported
Class I00% of total
Ongoing8latest 5 Nov 2025
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 8 100%Class III 0 0%
Why lisdexamfetamine dimesylate is recalled
Companies
Product types
By year
Ongoing lisdexamfetamine dimesylate recalls
8 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Lisdexamfetamine Dimesylate Capsules, 30 mg, CII recalledLisdexamfetamine Dimesylate | SUN Pharmaceutical Industries | Potency & Assay | Nationwide |
| Drug | CLASS II | Lisdexamfetamine Dimesylate Capsules, 40 mg, CII recalledLisdexamfetamine Dimesylate | SUN Pharmaceutical Industries | Potency & Assay | Nationwide |
| Drug | CLASS II | Lisdexamfetamine Dimesylate Capsules, 10 mg, CII recalledLisdexamfetamine Dimesylate | SUN Pharmaceutical Industries | Potency & Assay | Nationwide |
| Drug | CLASS II | Lisdexamfetamine Dimesylate Capsules, 20 mg, CII recalledLisdexamfetamine Dimesylate | SUN Pharmaceutical Industries | Potency & Assay | Nationwide |
| Drug | CLASS II | Lisdexamfetamine Dimesylate Capsules, 70 mg, CII recalledLisdexamfetamine Dimesylate | SUN Pharmaceutical Industries | Potency & Assay | Nationwide |
| Drug | CLASS II | Lisdexamfetamine Dimesylate Capsules, 50 mg, CII recalledLisdexamfetamine Dimesylate | SUN Pharmaceutical Industries | Potency & Assay | Nationwide |
All lisdexamfetamine dimesylate recalls, newest first
8 totalAbout this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.